Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer

International Journal of Cancer

Volumn 135, Issue 3, 2014, Pages 611-623

  Cajuso, Tatiana ^a   Hänninen, Ulrika A ^a   Kondelin, Johanna ^a   Gylfe, Alexandra E ^a   Tanskanen, Tomas ^a   Katainen, Riku ^a   Pitkänen, Esa ^a   Ristolainen, Heikki ^a   Kaasinen, Eevi ^a   Taipale, Minna ^b,c   Taipale, Jussi ^b,c   Böhm, Jan ^d   Renkonen Sinisalo, Laura ^e   Mecklin, Jukka Pekka ^d   Järvinen, Heikki ^e   Tuupanen, Sari ^a   Kilpivaara, Outi ^a   Vahteristo, Pia ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

ARID1A; ARID1B; ARID2; ARID4A; Colorectal cancer

Indexed keywords

ARID1A GENE; ARID1B GENE; ARID2 GENE; ARID4A GENE; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; EXOME; FEMALE; FRAMESHIFT MUTATION; GENE FREQUENCY; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; MALE; MICROSATELLITE INSTABILITY; MUTATIONAL ANALYSIS; NONSENSE MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOMATIC MUTATION; TUMOR GENE; VALIDATION PROCESS;

ARID1A; ARID1B; ARID2; ARID4A; COLORECTAL CANCER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COLORECTAL NEOPLASMS; DNA-BINDING PROTEINS; EXOME; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MICROSATELLITE INSTABILITY; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; RETINOBLASTOMA-BINDING PROTEIN 1; TRANSCRIPTION FACTORS;

EID: 84901011543     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28705     Document Type: Article

References (49)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487: 330-7.
3. Vogelstein B, Papadopoulos N, Velculescu VE, et al. Cancer genome landscapes. Science 2013; 339: 1546-58.
4. Rajagopalan H, Bardelli A, Lengauer C, et al. Tumorigenesis: Raf/ras oncogenes and mismatch-repair status. Nature 2002; 418: 934.
5. Gylfe AE, Kondelin J, Turunen M, et al. Identification of candidate oncogenes in human colorectal cancers with microsatellite instability. Gastroenterology 2013; 145: 540-3. e522.
6. Jones S, Wang TL, Shih IM, et al. Frequent mutations of chromatin remodeling gene arid1a in ovarian clear cell carcinoma. Science 2010; 330: 228-31.
7. Wiegand KC, Shah SP, Al-Agha OM, et al. Arid1a mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 2010; 363: 1532-43.
8. Wang K, Kan J, Yuen ST, et al. Exome sequencing identifies frequent mutation of arid1a in molecular subtypes of gastric cancer. Nat Genet 2011; 43: 1219-23.
9. Shain AH, Giacomini CP, Matsukuma K, et al. Convergent structural alterations define switch/sucrose nonfermentable (swi/snf) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer. Proc Natl Acad Sci USA 2012; 109: E252-9.
10. Mamo A, Cavallone L, Tuzmen S, et al. An integrated genomic approach identifies arid1a as a candidate tumor-suppressor gene in breast cancer. Oncogene 2012; 31: 2090-100.
11. Jones S, Li M, Parsons DW, et al. Somatic mutations in the chromatin remodeling gene arid1a occur in several tumor types. Hum Mutat 2012; 33: 100-3.
12. Guichard C, Amaddeo G, Imbeaud S, et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 2012; 44: 694-8.
13. Gui Y, Guo G, Huang Y, et al. Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet 2011; 43: 875-8.
14. Treon SP, Xu L, Yang G, et al. Myd88 l265p somatic mutation in waldenstrom's macroglobulinemia. N Engl J Med 2012; 367: 826-33.
15. Allo G, Bernardini MQ, Wu RC, et al. Arid1a loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas. Mod Pathol; in press. doi: 10.1038/modpathol.2013.144.
16. Wilsker D, Patsialou A, Dallas PB, et al. Arid proteins: a diverse family of DNA binding proteins implicated in the control of cell growth, differentiation, and development. Cell Growth Differ 2002; 13: 95-106.
17. Patsialou A, Wilsker D, Moran E,. DNA-binding properties of arid family proteins. Nucleic Acids Res 2005; 33: 66-80.
18. Aaltonen LA, Salovaara R, Kristo P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998; 338: 1481-7.
19. Salovaara R, Loukola A, Kristo P, et al. Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 2000; 18: 2193-200.
20. Saarinen S, Kaasinen E, Karjalainen-Lindsberg ML, et al. Primary mediastinal large b-cell lymphoma segregating in a family: exome sequencing identifies mll as a candidate predisposition gene. Blood 2013; 121: 3428-30.
21. Li H, Durbin R,. Fast and accurate short read alignment with burrows-wheeler transform. Bioinformatics 2009; 25: 1754-60.
22. DePristo MA, Banks E, Poplin R, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 2011; 43: 491-8.
23. Sherry ST, Ward MH, Kholodov M, et al. Dbsnp: the ncbi database of genetic variation. Nucleic Acids Res 2001; 29: 308-11.
24. Abecasis GR, Auton A, Brooks LD, et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012; 491: 56-65.
25. Flicek P, Ahmed I, Amode MR, et al. Ensembl 2013. Nucleic Acids Res 2013; 41: D48-55.
26. Cornen S, Adelaide J, Bertucci F, et al. Mutations and deletions of arid1a in breast tumors. Oncogene 2012; 31: 4255-6.
27. Wu JN, Roberts CW,. Arid1a mutations in cancer: another epigenetic tumor suppressor? Cancer Discov 2013; 3: 35-43.
28. Wang X, Nagl NG, Wilsker D, et al. Two related arid family proteins are alternative subunits of human swi/snf complexes. Biochem J 2004; 383: 319-25.
29. Sammalkorpi H, Alhopuro P, Lehtonen R, et al. Background mutation frequency in microsatellite-unstable colorectal cancer. Cancer Res 2007; 67: 5691-8.
30. Fujimoto A, Totoki Y, Abe T, et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet 2012; 44: 760-4.
31. Dulak AM, Stojanov P, Peng S, et al. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet 2013; 45: 478-6.
32. Sausen M, Leary RJ, Jones S, et al. Integrated genomic analyses identify arid1a and arid1b alterations in the childhood cancer neuroblastoma. Nat Genet 2013; 45: 12-7.
33. Kadoch C, Hargreaves DC, Hodges C, et al. Proteomic and bioinformatic analysis of mammalian swi/snf complexes identifies extensive roles in human malignancy. Nat Genet 2013; 45: 592-601.
34. Shain AH, Pollack JR,. The spectrum of swi/snf mutations, ubiquitous in human cancers. PLoS One 2013; 8: e55119.
35. Nagl NG, Jr, Wang X, Patsialou A, et al. Distinct mammalian swi/snf chromatin remodeling complexes with opposing roles in cell-cycle control. EMBO J 2007; 26: 752-63.
36. Stephens PJ, Tarpey PS, Davies H, et al. The landscape of cancer genes and mutational processes in breast cancer. Nature 2012; 486: 400-4.
37. Yan Z, Cui K, Murray DM, et al. Pbaf chromatin-remodeling complex requires a novel specificity subunit, baf200, to regulate expression of selective interferon-responsive genes. Genes Dev 2005; 19: 1662-7.
38. Xu F, Flowers S, Moran E,. Essential role of arid2 protein-containing swi/snf complex in tissue-specific gene expression. J Biol Chem 2012; 287: 5033-41.
39. Li M, Zhao H, Zhang X, et al. Inactivating mutations of the chromatin remodeling gene arid2 in hepatocellular carcinoma. Nat Genet 2011; 43: 828-9.
40. Manceau G, Letouze E, Guichard C, et al. Recurrent inactivating mutations of arid2 in non-small cell lung carcinoma. Int J Cancer 2013; 132: 2217-21.
41. Biankin AV, Waddell N, Kassahn KS, et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 2012; 491: 399-405.
42. Hodis E, Watson IR, Kryukov GV, et al. A landscape of driver mutations in melanoma. Cell 2012; 150: 251-63.
43. Chittenden T, Livingston DM, Kaelin WG, Jr,. The t/e1a-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell 1991; 65: 1073-82.
44. Lai A, Lee JM, Yang WM, et al. Rbp1 recruits both histone deacetylase-dependent and-independent repression activities to retinoblastoma family proteins. Mol Cell Biol 1999; 19: 6632-41.
45. Rodrigues-Lisoni FC, Peitl P, Jr, Vidotto A, et al. Genomics and proteomics approaches to the study of cancer-stroma interactions. BMC Med Genomics 2010; 3: 14.
46. Hurst DR, Xie Y, Vaidya KS, et al. Alterations of brms1-arid4a interaction modify gene expression but still suppress metastasis in human breast cancer cells. J Biol Chem 2008; 283: 7438-44.
47. Wu MY, Eldin KW, Beaudet AL,. Identification of chromatin remodeling genes arid4a and arid4b as leukemia suppressor genes. J Natl Cancer Inst 2008; 100: 1247-59.
48. Khursheed M, Kolla JN, Kotapalli V, et al. Arid1b, a member of the human swi/snf chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell lines. Br J Cancer 2013; 108: 2056-62.
49. Tsurusaki Y, Okamoto N, Ohashi H, et al. Mutations affecting components of the swi/snf complex cause coffin-siris syndrome. Nat Genet 2012; 44: 376-8.